ATXI

MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and…

<!-- Name:DistributionId Value:8784513 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…